Header Logo

Connection

Igor Koralnik to Male

This is a "connection" page, showing publications Igor Koralnik has written about Male.
Connection Strength

2.122
  1. Evolution of neurologic symptoms in non-hospitalized COVID-19 "long haulers". Ann Clin Transl Neurol. 2022 07; 9(7):950-961.
    View in: PubMed
    Score: 0.066
  2. LTA4H Prevalence and Mortality in Adult Zambians with Tuberculous Meningitis. Ann Neurol. 2021 12; 90(6):994-998.
    View in: PubMed
    Score: 0.063
  3. Persistent neurologic symptoms and cognitive dysfunction in non-hospitalized Covid-19 "long haulers". Ann Clin Transl Neurol. 2021 05; 8(5):1073-1085.
    View in: PubMed
    Score: 0.061
  4. Frequent neurologic manifestations and encephalopathy-associated morbidity in Covid-19 patients. Ann Clin Transl Neurol. 2020 11; 7(11):2221-2230.
    View in: PubMed
    Score: 0.059
  5. Children with Narcolepsy type 1 have increased T-cell responses to orexins. Ann Clin Transl Neurol. 2019 12; 6(12):2566-2572.
    View in: PubMed
    Score: 0.055
  6. Prospective Cohort Study on Performance of Cerebrospinal Fluid (CSF) Xpert MTB/RIF, CSF Lipoarabinomannan (LAM) Lateral Flow Assay (LFA), and Urine LAM LFA for Diagnosis of Tuberculous Meningitis in Zambia. J Clin Microbiol. 2019 08; 57(8).
    View in: PubMed
    Score: 0.054
  7. Progressive multifocal leukoencephalopathy in Zambia is caused by JC virus with prototype regulatory region. J Neurovirol. 2019 08; 25(4):475-479.
    View in: PubMed
    Score: 0.053
  8. PML-IRIS in an HIV-2-infected patient presenting as Bell's palsy. J Neurovirol. 2017 10; 23(5):789-792.
    View in: PubMed
    Score: 0.047
  9. Predictors and characteristics of seizures in survivors of progressive multifocal leukoencephalopathy. J Neurovirol. 2016 08; 22(4):464-71.
    View in: PubMed
    Score: 0.042
  10. Brief Report: Role of Thymic Reconstitution in the Outcome of AIDS-Related PML. J Acquir Immune Defic Syndr. 2015 Dec 01; 70(4):357-61.
    View in: PubMed
    Score: 0.042
  11. Simian Virus 40 Infection in the Spinal Cord of Simian Immunodeficiency Virus-Immunosuppressed Rhesus Macaques. J Neuropathol Exp Neurol. 2015 Nov; 74(11):1071-6.
    View in: PubMed
    Score: 0.042
  12. Lack of Major Histocompatibility Complex Class I Upregulation and Restrictive Infection by JC Virus Hamper Detection of Neurons by T Lymphocytes in the Central Nervous System. J Neuropathol Exp Neurol. 2015 Aug; 74(8):791-803.
    View in: PubMed
    Score: 0.041
  13. Progressive neurologic dysfunction in a psoriasis patient treated with dimethyl fumarate. Ann Neurol. 2015 Oct; 78(4):501-14.
    View in: PubMed
    Score: 0.041
  14. JCV GCN in a natalizumab-treated MS patient is associated with mutations of the VP1 capsid gene. Neurology. 2014 Aug 19; 83(8):727-32.
    View in: PubMed
    Score: 0.038
  15. JC virus reactivation during prolonged natalizumab monotherapy for multiple sclerosis. Ann Neurol. 2014 Jun; 75(6):925-34.
    View in: PubMed
    Score: 0.038
  16. Hyperintense cortical signal on magnetic resonance imaging reflects focal leukocortical encephalitis and seizure risk in progressive multifocal leukoencephalopathy. Ann Neurol. 2014 May; 75(5):659-69.
    View in: PubMed
    Score: 0.037
  17. Immune reconstitution after allogeneic hematopoietic stem cell transplantation is associated with selective control of JC virus reactivation. Biol Blood Marrow Transplant. 2014 Jul; 20(7):992-9.
    View in: PubMed
    Score: 0.037
  18. Molecular diagnosis of central nervous system opportunistic infections in HIV-infected Zambian adults. Clin Infect Dis. 2014 Jun; 58(12):1771-7.
    View in: PubMed
    Score: 0.037
  19. Hyperperfusion in progressive multifocal leukoencephalopathy is associated with disease progression and absence of immune reconstitution inflammatory syndrome. Brain. 2013 Nov; 136(Pt 11):3441-50.
    View in: PubMed
    Score: 0.036
  20. Inflammatory infratentorial progressive multifocal leukoencephalopathy in a patient with rheumatoid arthritis. Neuropathology. 2014 Feb; 34(1):39-44.
    View in: PubMed
    Score: 0.035
  21. A game of viral hide and seek: miliary PML masquerading as EBV encephalitis in an HIV+ patient. Clin Neurol Neurosurg. 2013 Sep; 115(9):1861-3.
    View in: PubMed
    Score: 0.035
  22. Comment: avoiding detrimental effects of corticosteroids on JC virus T-cell responses--primum non nocere. Neurology. 2012 Dec 04; 79(23):2263.
    View in: PubMed
    Score: 0.034
  23. Simultaneous PML-IRIS after discontinuation of natalizumab in a patient with MS. Neurology. 2012 Nov 20; 79(21):2160; author reply 2160.
    View in: PubMed
    Score: 0.034
  24. Metabolic profile of PML lesions in patients with and without IRIS: an observational study. Neurology. 2012 Sep 04; 79(10):1041-8.
    View in: PubMed
    Score: 0.033
  25. Increased program cell death-1 expression on T lymphocytes of patients with progressive multifocal leukoencephalopathy. J Acquir Immune Defic Syndr. 2012 Jul 01; 60(3):244-8.
    View in: PubMed
    Score: 0.033
  26. JC virus encephalopathy is associated with a novel agnoprotein-deletion JCV variant. PLoS One. 2012; 7(4):e35793.
    View in: PubMed
    Score: 0.033
  27. Simultaneous PML-IRIS after discontinuation of natalizumab in a patient with MS. Neurology. 2012 May 01; 78(18):1390-3.
    View in: PubMed
    Score: 0.033
  28. Progressive multifocal leukoencephalopathy in a patient without immunodeficiency. Neurology. 2012 Jan 03; 78(1):73; author response 73-4.
    View in: PubMed
    Score: 0.032
  29. JC virus granule cell neuronopathy is associated with VP1 C terminus mutants. J Gen Virol. 2012 Jan; 93(Pt 1):175-183.
    View in: PubMed
    Score: 0.031
  30. Hidden in plain view: emergence of progressive multifocal leukoencephalopathy after treatment of CNS toxoplasmosis. Acta Neurol Belg. 2011 Sep; 111(3):217-9.
    View in: PubMed
    Score: 0.031
  31. JC virus antibody and viremia as predictors of progressive multifocal leukoencephalopathy in human immunodeficiency virus-1-infected individuals. Clin Infect Dis. 2011 Oct; 53(7):711-5.
    View in: PubMed
    Score: 0.031
  32. Clinical outcome of long-term survivors of progressive multifocal leukoencephalopathy. J Neurol Neurosurg Psychiatry. 2010 Nov; 81(11):1288-91.
    View in: PubMed
    Score: 0.029
  33. The spectrum of neurological disorders in a Zambian tertiary care hospital. J Neurol Sci. 2010 Mar 15; 290(1-2):1-5.
    View in: PubMed
    Score: 0.028
  34. Determinants of survival in progressive multifocal leukoencephalopathy. Neurology. 2009 Nov 10; 73(19):1551-8.
    View in: PubMed
    Score: 0.027
  35. Progressive multifocal leukoencephalopathy in individuals with minimal or occult immunosuppression. J Neurol Neurosurg Psychiatry. 2010 Mar; 81(3):247-54.
    View in: PubMed
    Score: 0.027
  36. Asymptomatic reactivation of JC virus in patients treated with natalizumab. N Engl J Med. 2009 Sep 10; 361(11):1067-74.
    View in: PubMed
    Score: 0.027
  37. Frequent infection of cerebellar granule cell neurons by polyomavirus JC in progressive multifocal leukoencephalopathy. J Neuropathol Exp Neurol. 2009 Jan; 68(1):15-25.
    View in: PubMed
    Score: 0.026
  38. Rearrangement of the JC virus regulatory region sequence in the bone marrow of a patient with rheumatoid arthritis and progressive multifocal leukoencephalopathy. J Neurovirol. 2008 Oct; 14(5):455-8.
    View in: PubMed
    Score: 0.026
  39. Spinal cord lesions of progressive multifocal leukoencephalopathy in an acquired immunodeficiency syndrome patient. J Neurovirol. 2007 Oct; 13(5):474-6.
    View in: PubMed
    Score: 0.024
  40. Remission of progressive multifocal leukoencephalopathy and primary central nervous system lymphoma in an HIV-infected patient. Eur J Neurol. 2007 Jun; 14(6):598-602.
    View in: PubMed
    Score: 0.023
  41. Characterization of lymphocytic infiltrates in progressive multifocal leukoencephalopathy: co-localization of CD8(+) T cells with JCV-infected glial cells. J Neurovirol. 2006 Apr; 12(2):116-28.
    View in: PubMed
    Score: 0.021
  42. Seizures and their outcome in progressive multifocal leukoencephalopathy. Neurology. 2006 Jan 24; 66(2):262-4.
    View in: PubMed
    Score: 0.021
  43. Presence of JC virus-specific CTL in the cerebrospinal fluid of PML patients: rationale for immune-based therapeutic strategies. AIDS. 2005 Dec 02; 19(18):2069-76.
    View in: PubMed
    Score: 0.021
  44. Progressive multifocal leukoencephalopathy as a complication of hepatitis C virus treatment in an HIV-negative patient. Clin Infect Dis. 2005 Aug 01; 41(3):417-9.
    View in: PubMed
    Score: 0.020
  45. Elevation of myoinositol is associated with disease containment in progressive multifocal leukoencephalopathy. Neurology. 2004 Sep 14; 63(5):897-900.
    View in: PubMed
    Score: 0.019
  46. A prospective study demonstrates an association between JC virus-specific cytotoxic T lymphocytes and the early control of progressive multifocal leukoencephalopathy. Brain. 2004 Sep; 127(Pt 9):1970-8.
    View in: PubMed
    Score: 0.019
  47. Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 14-2004. A 66-year-old man with progressive neurologic deficits. N Engl J Med. 2004 Apr 29; 350(18):1882-93.
    View in: PubMed
    Score: 0.019
  48. Productive infection of cerebellar granule cell neurons by JC virus in an HIV+ individual. Neurology. 2003 Sep 23; 61(6):775-82.
    View in: PubMed
    Score: 0.018
  49. Inflammatory reaction in progressive multifocal leukoencephalopathy: harmful or beneficial? J Neurovirol. 2003; 9 Suppl 1:25-31.
    View in: PubMed
    Score: 0.017
  50. The case of a 42-year-old man with progressive gait instability, dysarthria, and dysphagia. Ann Clin Transl Neurol. 2023 01; 10(1):144-145.
    View in: PubMed
    Score: 0.017
  51. Clinical presentation and outcomes of syphilitic meningitis among hospitalized adults in lusaka, Zambia. Int J STD AIDS. 2022 10; 33(12):1038-1044.
    View in: PubMed
    Score: 0.017
  52. Persistent viral RNA shedding of SARS-CoV-2 is associated with delirium incidence and six-month mortality in hospitalized COVID-19 patients. Geroscience. 2022 06; 44(3):1241-1254.
    View in: PubMed
    Score: 0.016
  53. Clinical characteristics and outcomes after new-onset seizure among Zambian children with HIV during the antiretroviral therapy era. Epilepsia Open. 2022 06; 7(2):315-324.
    View in: PubMed
    Score: 0.016
  54. Cross-protective immunity following coronavirus vaccination and coronavirus infection. J Clin Invest. 2021 12 15; 131(24).
    View in: PubMed
    Score: 0.016
  55. Progressive Multifocal Leukoencephalopathy in a Patient With Progressive Multiple Sclerosis Treated With Ocrelizumab Monotherapy. JAMA Neurol. 2021 06 01; 78(6):736-740.
    View in: PubMed
    Score: 0.015
  56. Abnormal movements in hospitalized COVID-19 patients: A case series. J Neurol Sci. 2021 04 15; 423:117377.
    View in: PubMed
    Score: 0.015
  57. Transcranial Doppler Ultrasound Evidence of Active Cerebral Embolization in COVID-19. J Stroke Cerebrovasc Dis. 2021 Mar; 30(3):105542.
    View in: PubMed
    Score: 0.015
  58. Clinicopathological characterization of an HIV-2-infected individual with two clonally unrelated primary lymphomas. Am J Hematol. 2000 Dec; 65(4):302-6.
    View in: PubMed
    Score: 0.015
  59. Brainstem progressive multifocal leukoencephalopathy. Eur J Neurol. 2021 03; 28(3):1016-1021.
    View in: PubMed
    Score: 0.015
  60. Evaluating the impact of antiretroviral and antiseizure medication interactions on treatment effectiveness among outpatient clinic attendees with HIV in Zambia. Epilepsia. 2020 12; 61(12):2705-2711.
    View in: PubMed
    Score: 0.015
  61. Risk factors for lymphopenia in patients with relapsing-remitting multiple sclerosis treated with dimethyl fumarate. J Neurol. 2020 01; 267(1):125-131.
    View in: PubMed
    Score: 0.014
  62. Brief Report: Decreased JC Virus-Specific Antibody-Dependent Cellular Cytotoxicity in HIV-Seropositive PML Survivors. J Acquir Immune Defic Syndr. 2019 10 01; 82(2):220-224.
    View in: PubMed
    Score: 0.014
  63. Neurosyphilis. Semin Neurol. 2019 08; 39(4):448-455.
    View in: PubMed
    Score: 0.014
  64. Treatment of natalizumab-associated PML with filgrastim. Ann Clin Transl Neurol. 2019 May; 6(5):923-931.
    View in: PubMed
    Score: 0.013
  65. Mortality & recurrent seizure risk after new-onset seizure in HIV-positive Zambian adults. BMC Neurol. 2018 Dec 07; 18(1):201.
    View in: PubMed
    Score: 0.013
  66. Neurologic illness in Zambia: A neurointensivist's experience. J Neurol Sci. 2018 02 15; 385:140-143.
    View in: PubMed
    Score: 0.012
  67. A Difficult Decision: Atypical JC Polyomavirus Encephalopathy in a Kidney Transplant Recipient. Transplantation. 2017 06; 101(6):1461-1467.
    View in: PubMed
    Score: 0.012
  68. Temporal Patterns and Drug Resistance in CSF Viral Escape Among ART-Experienced HIV-1 Infected Adults. J Acquir Immune Defic Syndr. 2017 06 01; 75(2):246-255.
    View in: PubMed
    Score: 0.012
  69. New-onset seizure in HIV-infected adult Zambians: A search for causes and consequences. Neurology. 2017 01 31; 88(5):477-482.
    View in: PubMed
    Score: 0.011
  70. Fulminant Myocarditis with Combination Immune Checkpoint Blockade. N Engl J Med. 2016 Nov 03; 375(18):1749-1755.
    View in: PubMed
    Score: 0.011
  71. JC virus granule cell neuronopathy in the setting of chronic lymphopenia treated with recombinant interleukin-7. J Neurovirol. 2017 02; 23(1):141-146.
    View in: PubMed
    Score: 0.011
  72. Recurrence of progressive multifocal leukoencephalopathy despite immune recovery in two HIV seropositive individuals. J Neurovirol. 2016 08; 22(4):541-5.
    View in: PubMed
    Score: 0.011
  73. HIV and new onset seizures: slipping through the cracks in HIV care and treatment. HIV Med. 2016 Feb; 17(2):118-23.
    View in: PubMed
    Score: 0.010
  74. Acute EEG findings in HIV-infected Zambian adults with new-onset seizure. Neurology. 2015 Mar 31; 84(13):1317-22.
    View in: PubMed
    Score: 0.010
  75. BK polyomavirus reactivation after reduced-intensity double umbilical cord blood cell transplantation. Transpl Immunol. 2015 Mar; 32(2):116-20.
    View in: PubMed
    Score: 0.010
  76. Cognitive impairment and psychiatric morbidity in HIV+ Zambians with new-onset seizure. Am J Trop Med Hyg. 2014 Dec; 91(6):1254-8.
    View in: PubMed
    Score: 0.010
  77. JC polyomavirus granule cell neuronopathy in a patient treated with rituximab. JAMA Neurol. 2014 Apr; 71(4):487-9.
    View in: PubMed
    Score: 0.009
  78. Progressive multifocal leukoencephalopathy in pediatric patients: case report and literature review. Pediatr Infect Dis J. 2014 Apr; 33(4):e99-105.
    View in: PubMed
    Score: 0.009
  79. PML diagnostic criteria: consensus statement from the AAN Neuroinfectious Disease Section. Neurology. 2013 Apr 09; 80(15):1430-8.
    View in: PubMed
    Score: 0.009
  80. EEG findings in asymptomatic HIV. Neurology. 1993 Mar; 43(3 Pt 1):635-6.
    View in: PubMed
    Score: 0.009
  81. Progressive multifocal leukoencephalopathy in a patient without immunodeficiency. Neurology. 2011 Jul 19; 77(3):297-9.
    View in: PubMed
    Score: 0.008
  82. A controlled study of early neurologic abnormalities in men with asymptomatic human immunodeficiency virus infection. N Engl J Med. 1990 Sep 27; 323(13):864-70.
    View in: PubMed
    Score: 0.007
  83. Favourable outcome of progressive multifocal leucoencephalopathy in two patients with dermatomyositis. J Neurol Neurosurg Psychiatry. 2006 Sep; 77(9):1079-82.
    View in: PubMed
    Score: 0.006
  84. BK virus-associated hemorrhagic cystitis in a Human Immunodeficiency Virus-infected patient. Clin Infect Dis. 2002 Aug 01; 35(3):326-9.
    View in: PubMed
    Score: 0.004
  85. [Effect of antiretroviral treatment on early electroencephalographic and otoneurologic manifestations in HIV infection and prognostic importance of verified perturbations]. Neurophysiol Clin. 1997 Dec; 27(6):508-19.
    View in: PubMed
    Score: 0.003
  86. Mesencephalic clefts with associated eye movement disorders. Arch Ophthalmol. 1996 Apr; 114(4):429-32.
    View in: PubMed
    Score: 0.003
  87. Phylogenetic study of ten new HTLV-I strains from the Americas. AIDS Res Hum Retroviruses. 1994 Jan; 10(1):103-6.
    View in: PubMed
    Score: 0.002
  88. Neuro-otological manifestations in different stages of HIV infection. Acta Otolaryngol Suppl. 1991; 481:515-21.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.